Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT® Autoinjector: A Prospective Observational Cohort Study

by Wolfgang Köhler, Kirsten Bayer-Gersmann, Thomas Neußer, Markus Schürks, Tjalf Ziemssen
Published 2021-02-01

Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort...

by Sylvia Kotterba, Thomas Neusser, Christiane Norenberg, Patrick Bussfeld, Thomas Glaser, Martin Dörner, Markus Schürks
Published 2018-08-01